Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss

Renal Failure

Volumn 32, Issue 3, 2010, Pages 372-379

  Wang, Gang ^a   Lai, Fernand Mac Moune ^a   Lai, Ka Bik ^a   Chow, Kai Ming ^a   Kwan, Bonnie Ching Ha ^a   Li, Kam Tao Philip ^a   Szeto, Cheuk Chun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Diabetes mellitus; Gene expression; Podocyte number

Indexed keywords

NEPHRIN; PODOCIN; SYNAPTOPODIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; FEMALE; GENE EXPRESSION; GLOMERULUS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

BIOPSY; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KIDNEY GLOMERULUS; MALE; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; MIDDLE AGED; PODOCYTES; RNA, MESSENGER;

EID: 77950569000     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860221003611737     Document Type: Article

References (37)

1. Cooper L. USRDS annual data report. Nephrol News Issues. 2001;15:31-38.
2. Dagogo-Jack S. Primary prevention of type-2 diabetes in developing countries. J Natl Med Assoc. 2006;98:415-419. (Pubitemid 43352534)
3. Marshall SM. The podocyte: A major player in the development of diabetic nephropathy? Horm Metab Res. 2005;37:9-16.
4. White KE, Bilous RW. Diabiopsies study G: Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant. 2004;19:1437-1440.
5. White KE, Bilous RW, Marshall SM, et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes. 2002;51:3083-3089.
6. Macconi D, Bonomelli M, Benigni A, et al. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol. 2006;168:42-54. (Pubitemid 43062558)
7. Kriz W, Lemley KV. The role of the podocyte in glomerulosclerosis. Curr Opin Nephrol Hypertens. 1999;8:489-497. (Pubitemid 30004174)
8. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest. 1997;99:342-348. (Pubitemid 27053474)
9. Shirato I, Hishiki T, Tomino Y. Podocyte loss and progression of diabetic nephropathy. Contrib Nephrol. 2001;134:69-73. (Pubitemid 33339451)
10. Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes. 2003;52: 1031-1035. (Pubitemid 36384274)
11. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol. 2002;13:3005-3015. (Pubitemid 35386921)
12. Petermann AT, Pippin J, Krofft R, et al. Viable podocytes detach in experimental diabetic nephropathy: Potential mechanism underlying glomerulosclerosis. Nephron Exp Nephrol. 2004;98:e114-e123.
13. Petermann AT, Krofft R, Blonski M, et al. Podocytes that detach in experimental membranous nephropathy are viable [see comment]. Kidney Int. 2003;64:1222-1231.
14. Vogelmann SU, Nelson WJ, Myers BD, Lemley KV. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol. 2003;285:F40-F48.
15. Camici M. Urinary detection of podocyte injury. Biomed Pharmacother. 2007;61:245-249.
16. Hara M, Yanagihara T, Itoh M, Matsuno M, Kihara I. Immunohistochemical and urinary markers of podocyte injury. Pediatr Nephrol. 1998;12:43-48.
17. Patari A, Forsblom C, Havana M, Taipale H, Groop PH, Holthofer H. Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes. 2003;52:2969-2974.
18. Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, Floege J. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol. 2005;16:1733-1741.
19. Wang G, Lai F-M, Lai K-B, Chow K-M, Li K-TP, Szeto C-C. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy. Nephron Clin Pract. 2007;106:c169-c179. (Pubitemid 47172277)
20. Szeto CC, Lai KB, Chow KM, et al. Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases. Clin Chim Acta. 2005;361: 182-190.
21. Wirta O, Helin H, Mustonen J, Kuittinen E, Savela T, Pasternack A. Renal findings and glomerular pathology in diabetic subjects. Nephron. 2000;84:236-242.
22. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group [see comment]. Ann Intern Med. 1999;130:461-470.
23. Weibel ER. Stereological Methods. Practical Methods for Biological Morphometry. Vol 1. London: Academic Press, Inc.; 1979:40-116.
24. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 1999; 10:51-61.
25. Najafian B, Basgen JM, Mauer M. Estimating mean glomerular volume using two arbitrary parallel sections. J Am Soc Nephrol. 2002;13:2697-2705.
26. Bruneval P, Bariety J, Belair MF, Mandet C, Heudes D, Nicoletti A. Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice. Nephrol Dial Transplant. 2002;17:2099-2107.
27. Li B, Hartono C, Ding R, et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med. 2001;344:947-954.
28. Szeto CC, Chan RW, Lai KB, et al. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases. Nephrol Dial Transplant. 2005; 20:105-113.
29. Biosystems FCCA. Guide to Performing Relative Quantitation of Gene Expression Using Real-Time Quantitative PCR; 2004.
30. Biosystems FCCA. Amplification Efficiency of TaqMan® Gene Expression Assays; 2006.
31. Basgen JM, Nicholas SB, Mauer M, Rozen S, Nyengaard JR. Comparison of methods for counting cells in the mouse glomerulus. Nephron Exp Nephrol. 2006;103:e139-e148.
32. White KE, Bilous RW. Estimation of podocyte number: A comparison of methods. Kidney Int. 2004;66:663-667.
33. Siu B, Saha J, Smoyer WE, Sullivan KA, Brosius FC 3rd. Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: Prevention by lipoic acid treatment. BMC Nephrol. 2006;7:6.
34. Sanden SK, Wiggins JE, Goyal M, Riggs LK, Wiggins RC. Evaluation of a thick and thin section method for estimation of podocyte number, glomerular volume, and glomerular volume per podocyte in rat kidney with Wilms' Tumor-1 protein used as a podocyte nuclear marker. J Am Soc Nephrol. 2003; 14:2484-2493.
35. Langham RG, Kelly DJ, Cox AJ, et al. Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: Effects of angiotensin converting enzyme inhibition. Diabetologia. 2002;45:1572-1576.
36. Susztak K, Raff AC, Schiffer M, Böttinger EP. Glucoseinduced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes. 2006;55:225-233.
37. Kretzler M. Role of podocytes in focal sclerosis: Defining the point of no return [comment]. J Am Soc Nephrol. 2005;16:2830-2832.